Literature DB >> 8950858

Visceral artery aneurysms secondary to collateral circulation.

M Porcellini1, V Iaccarino, B Bernardo, N Migliucci, R Capasso.   

Abstract

OBJECTIVE: To evaluate dilatation of visceral arteries secondary to anomalies and collateral circulation.
DESIGN: Case report.
SETTING: Department of Vascular Surgery, University Hospital. PATIENTS: Two patients with secondary visceral aneurysms were reported. First patient (case 1) had a mid-aortic dysplastic syndrome with multiple aneurysms of the celiac trunk and right renal artery. Other patient (- case 2) presented an inferior pancreaticoduodenal artery aneurysm associated with proximal common hepatic artery occlusion.
INTERVENTIONS: The case 1 was submitted to aortic and left renal artery angioplasty (PTFEE), while in the case 2 the resection of aneurysm was performed.
RESULTS: Both patients had complete resolution of symptoms and are alive today.
CONCLUSIONS: Clinical observations confirmed the development of visceral artery aneurysms secondary to arterial hypertension and collateral circulation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8950858

Source DB:  PubMed          Journal:  Minerva Cardioangiol        ISSN: 0026-4725            Impact factor:   1.347


  3 in total

1.  Celiac artery aneurysm: a case report.

Authors:  D Michael McMullan; Michael McBride; James J Livesay; Kathryn G Dougherty; Zvonimir Krajcer
Journal:  Tex Heart Inst J       Date:  2006

2.  Inferior pancreaticoduodenal artery aneurysms in association with celiac stenosis/occlusion.

Authors:  Rekha Kallamadi; Marc A Demoya; Sanjeeva P Kalva
Journal:  Semin Intervent Radiol       Date:  2009-09       Impact factor: 1.513

Review 3.  Combined Treatment of Multiple Splanchnic Artery Aneurysms Secondary to Median Arcuate Ligament Syndrome: A Case Study and Review of the Literature.

Authors:  Piotr Kaszczewski; Jerzy Leszczyński; Michał Elwertowski; Rafał Maciąg; Witold Chudziński; Zbigniew Gałązka
Journal:  Am J Case Rep       Date:  2020-08-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.